INY-03-041 trihydrochloride
Product Specifications
Target
Akt, PROTACs
Related Pathways
Cytoskeletal Signaling, PROTAC, PI3K/Akt/mTOR signaling
Bioactivity
INY-03-041 trihydrochloride, a potent and highly selective PROTAC-based pan-AKT degrader, comprises Ipatasertib, an ATP-competitive AKT inhibitor, conjugated to Lenalidomide. It effectively inhibits AKT1, AKT2, and AKT3 with IC50 values of 2.0, 6.8, and 3.5 nM, respectively [1].
Molecular Formula
C44H59Cl4N7O5
Molecular Weight
907.8
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Mouse Monoclonal AKR7A3 Antibody (2E11) [DyLight 650]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP1-97944C 100 µL
Mouse Monoclonal AKR7A3 Antibody (2E11) [DyLight 650]
Sign In for Pricing
View Details 
IRBAMLKSR1AP205120UL 120 µL
Rabbit Anti KSR1 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Immunofluorescence) 120ul
Sign In for Pricing
View Details